SI1812797T1 - Pripravki in metode zdravljenja ter preprečevanja hiperprolifetarivnih bolezni - Google Patents

Pripravki in metode zdravljenja ter preprečevanja hiperprolifetarivnih bolezni

Info

Publication number: SI1812797T1
Authority: SI; Slovenia
Prior art keywords: prevention; compositions; treatment; methods; hyperproliferative diseases
Prior art date: 2004-10-28

Application number

SI200531702T

Other languages

English (en)

Inventor

Roger A. Sabbadini

Amy L. Cavalli

William Garland

Original Assignee

Lpath, Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-10-28

Filing date

2005-10-28

Publication date

2013-06-28

2005-10-28 Application filed by Lpath, Inc. filed Critical Lpath, Inc.

2013-06-28 Publication of SI1812797T1 publication Critical patent/SI1812797T1/sl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3076—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells against structure-related tumour-associated moieties
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Immunology (AREA)
Biophysics (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Urology & Nephrology (AREA)
Cell Biology (AREA)
Ophthalmology & Optometry (AREA)
Vascular Medicine (AREA)
Microbiology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

SI200531702T 2004-10-28 2005-10-28 Pripravki in metode zdravljenja ter preprečevanja hiperprolifetarivnih bolezni SI1812797T1 (sl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US62319704P	2004-10-28	2004-10-28
PCT/US2005/039303 WO2006078336A2 (en)	2004-10-28	2005-10-28	Compositions and methods for the treatment and prevention of hyperproliferative diseases
EP05818382A EP1812797B1 (en)	2004-10-28	2005-10-28	Compositions and methods for the treatment and prevention of hyperproliferative diseases

Publications (1)

Publication Number	Publication Date
SI1812797T1 true SI1812797T1 (sl)	2013-06-28

Family

ID=36692680

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI200531702T SI1812797T1 (sl)	2004-10-28	2005-10-28	Pripravki in metode zdravljenja ter preprečevanja hiperprolifetarivnih bolezni

Country Status (11)

Country	Link
EP (1)	EP1812797B1 (sl)
JP (1)	JP4982377B2 (sl)
AU (1)	AU2005325227B2 (sl)
CA (1)	CA2581061C (sl)
DK (1)	DK1812797T3 (sl)
ES (1)	ES2410866T3 (sl)
HK (1)	HK1102626A1 (sl)
PL (1)	PL1812797T3 (sl)
PT (1)	PT1812797E (sl)
SI (1)	SI1812797T1 (sl)
WO (1)	WO2006078336A2 (sl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7794713B2 (en) *	2004-04-07	2010-09-14	Lpath, Inc.	Compositions and methods for the treatment and prevention of hyperproliferative diseases
US7862812B2 (en) *	2006-05-31	2011-01-04	Lpath, Inc.	Methods for decreasing immune response and treating immune conditions
EP2083862A4 (en) *	2006-10-27	2012-09-19	Lpath Inc	COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES AND DISORDERS
US7829674B2 (en) *	2006-10-27	2010-11-09	Lpath, Inc.	Compositions and methods for binding sphingosine-1-phosphate
US20090004207A1 (en) *	2007-06-08	2009-01-01	Timothy Tun Hla	Methods and Compositions for Inhibiting Pathological Angiogenesis in the Eye
WO2017015334A1 (en) *	2015-07-21	2017-01-26	Saint Louis University	Compositions and methods for diagnosing and treating endometriosis-related infertility
US11758928B2 (en)	2016-12-15	2023-09-19	Société des Produits Nestlé S.A.	Compositions and methods that modulate phosphorus or enzymes in a companion animal

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5260288A (en) *	1992-04-03	1993-11-09	The Biomembrane Institute	Method for inhibition of cell motility by sphingosine-1-phosphate and derivatives
JPH09176083A (ja) *	1995-12-28	1997-07-08	Sankyo Co Ltd	新規化合物ｆ−１２５０９ａ
US6423527B1 (en) *	1997-09-29	2002-07-23	Children's Hospital Medical Center Of Northern California	Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
ES2316188T3 (es) *	1998-06-29	2009-04-01	Children's Hospital Los Angeles	Tratamiento de transtornos hiperproliferativos.
AUPQ744700A0 (en) *	2000-05-11	2000-06-01	Medvet Science Pty. Ltd.	A method of treatment and agents useful for same
AU2001288563A1 (en) *	2000-08-31	2002-03-13	University Of Connecticut	Regulation of angiogenesis via modulation of edg receptor mediated signal transduction comprising sphingosine-1-phosphate administration
CA2432978C (en) *	2000-12-22	2012-08-28	Medlyte, Inc.	Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor
US7674580B2 (en) *	2002-01-17	2010-03-09	Children's Hospital & Research Center At Oakland	Compositions and methods for the modulation of sphingolipid metabolism and/or signaling
PL372103A1 (en) *	2002-05-16	2005-07-11	Novartis Ag	Use of edg receptor binding agents in cancer

2005
- 2005-10-28 EP EP05818382A patent/EP1812797B1/en not_active Not-in-force
- 2005-10-28 JP JP2007539258A patent/JP4982377B2/ja not_active Expired - Fee Related
- 2005-10-28 DK DK05818382.3T patent/DK1812797T3/da active
- 2005-10-28 SI SI200531702T patent/SI1812797T1/sl unknown
- 2005-10-28 CA CA2581061A patent/CA2581061C/en not_active Expired - Fee Related
- 2005-10-28 PL PL05818382T patent/PL1812797T3/pl unknown
- 2005-10-28 PT PT58183823T patent/PT1812797E/pt unknown
- 2005-10-28 AU AU2005325227A patent/AU2005325227B2/en not_active Ceased
- 2005-10-28 WO PCT/US2005/039303 patent/WO2006078336A2/en active Application Filing
- 2005-10-28 ES ES05818382T patent/ES2410866T3/es active Active
2007
- 2007-10-09 HK HK07110891.2A patent/HK1102626A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
JP4982377B2 (ja)	2012-07-25
DK1812797T3 (da)	2013-05-21
WO2006078336A2 (en)	2006-07-27
EP1812797A2 (en)	2007-08-01
PL1812797T3 (pl)	2013-08-30
WO2006078336A3 (en)	2006-11-30
AU2005325227B2 (en)	2012-11-01
CA2581061A1 (en)	2006-07-27
EP1812797A4 (en)	2009-04-29
ES2410866T3 (es)	2013-07-03
PT1812797E (pt)	2013-05-21
CA2581061C (en)	2014-09-02
AU2005325227A1 (en)	2006-07-27
JP2008518946A (ja)	2008-06-05
EP1812797B1 (en)	2013-03-20
HK1102626A1 (en)	2007-11-30

Publication	Publication Date	Title
IL181896A0 (en)	2007-07-04	Methods and compositions for the treatment of hyperlipidemia
ZA200704677B (en)	2008-09-25	Compositions and methods for the treatment of autism
IL178860A (en)	2013-04-30	Certain chemical entities, preparations and processes
ZA200607433B (en)	2009-09-30	Methods and compositions for the treatment of gastroin-testinal disorders
IL182643A0 (en)	2007-07-24	Novel composition and methods for the treatment of immune related diseases
EP1737482A4 (en)	2010-09-15	COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES
ZA200703601B (en)	2008-09-25	Medicaments for the treatment or prevention of fibriotic diseases
IL177772A0 (en)	2006-12-31	Methods and compositions for the treatment of gastrointestinal disorders
IL177849A0 (en)	2006-12-31	Methods and compositions for treatment of autoimmune diseases
EP1755584A4 (en)	2007-10-31	TREATMENT OF MYOPIA
IL178996A0 (en)	2007-03-08	Thienopyridinone compounds and methods of treatment
IL174627A0 (en)	2006-08-20	Compositions and methods for treatment of burns
IL182436A0 (en)	2007-07-24	Thienopyridinone compounds and methods of treatment
EP1711197A4 (en)	2008-11-05	METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF INFLAMMATORY DISEASES OR DISORDERS
EP1858524A4 (en)	2011-03-30	COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNE DISEASES AND RELATED DISEASES
IL187405A0 (en)	2011-07-31	Methods and compositions for the treatment of pain
EP1786265A4 (en)	2009-08-19	NEW COMPOSITIONS AND PROCESSING METHODS
ZA200707955B (en)	2008-11-26	Methods and pharmaceutical compositions for the treatment of neurological damage
ZA200703087B (en)	2009-04-29	Methods and compositions for the treatment of hyperlipidemia
GB2441094B (en)	2010-11-03	Methods for treatment and prevention of infection
EP1765331A4 (en)	2007-12-05	METHODS AND COMPOSITIONS FOR THE TREATMENT OF PULMONARY DISEASES
EP1720563A4 (en)	2010-04-14	METHODS AND COMPOSITIONS FOR TREATING INFLAMMATION
PL1812797T3 (pl)	2013-08-30	Kompozycje i sposoby do leczenia chorób hiperproliferacyjnych i zapobiegania tym chorobom
EP1740221A4 (en)	2009-01-07	METHOD AND COMPOSITIONS FOR TREATING POLYCYSTIC DISEASES
EP1773349A4 (en)	2009-07-29	METHODS AND COMPOSITIONS FOR TREATING PREECLAMPSIA